New Requirement - Steritest Symbio ISL 2

The Food and Drug Administration has issued a forecast for a new requirement titled Steritest Symbio ISL 2, indicating an upcoming procurement opportunity under NAICS code 334516, which pertains to laboratory analytical instrument manufacturing. Although the solicitation number is not yet assigned and the contract type is listed as a forecast, this notice signals the agency’s intent to acquire equipment or services related to sterile testing systems, likely for use in regulatory or quality control operations. The place of performance and specific location details have not been provided, and no set-aside classification has been determined, suggesting the opportunity may be open to all eligible contractors. Contracting responsibilities are assigned to the FDA’s acquisition office, with the program point of contact listed as Oc Acquisition Liaison via email ocacquisitions@fda.hhs.gov. The contracting officer position is currently listed as to be determined, indicating that formal award procedures have not yet commenced. This forecast serves as an early indicator for industry participants to prepare proposals and align capabilities with the FDA’s needs, with the notice posted on May 25, 2026, and accessible through the official HHS opportunity portal. No funding or timeline specifics are included at this stage, but interested parties should monitor future updates for a formal solicitation.